GO:0042995 | cell projection | 100.0% (2/2) | 13.64 | 0.0 | 0.0 |
GO:0008360 | regulation of cell shape | 100.0% (2/2) | 13.09 | 0.0 | 0.0 |
GO:0007163 | establishment or maintenance of cell polarity | 100.0% (2/2) | 12.2 | 0.0 | 1e-06 |
GO:0019901 | protein kinase binding | 100.0% (2/2) | 11.79 | 0.0 | 1e-06 |
GO:0007264 | small GTPase mediated signal transduction | 100.0% (2/2) | 11.69 | 0.0 | 1e-06 |
GO:0022603 | regulation of anatomical structure morphogenesis | 100.0% (2/2) | 11.86 | 0.0 | 1e-06 |
GO:0030865 | cortical cytoskeleton organization | 100.0% (2/2) | 11.95 | 0.0 | 1e-06 |
GO:0022604 | regulation of cell morphogenesis | 100.0% (2/2) | 12.28 | 0.0 | 1e-06 |
GO:0032970 | regulation of actin filament-based process | 100.0% (2/2) | 11.09 | 0.0 | 1e-06 |
GO:0019900 | kinase binding | 100.0% (2/2) | 10.97 | 0.0 | 1e-06 |
GO:0032956 | regulation of actin cytoskeleton organization | 100.0% (2/2) | 11.11 | 0.0 | 1e-06 |
GO:0051493 | regulation of cytoskeleton organization | 100.0% (2/2) | 10.62 | 0.0 | 2e-06 |
GO:0050793 | regulation of developmental process | 100.0% (2/2) | 9.97 | 1e-06 | 5e-06 |
GO:0005856 | cytoskeleton | 100.0% (2/2) | 9.18 | 3e-06 | 1.4e-05 |
GO:0033043 | regulation of organelle organization | 100.0% (2/2) | 9.03 | 4e-06 | 1.6e-05 |
GO:0051128 | regulation of cellular component organization | 100.0% (2/2) | 8.72 | 6e-06 | 2.3e-05 |
GO:0032561 | guanyl ribonucleotide binding | 100.0% (2/2) | 8.11 | 1.3e-05 | 3.7e-05 |
GO:0005525 | GTP binding | 100.0% (2/2) | 8.11 | 1.3e-05 | 3.7e-05 |
GO:0003924 | GTPase activity | 100.0% (2/2) | 8.17 | 1.2e-05 | 3.7e-05 |
GO:0019001 | guanyl nucleotide binding | 100.0% (2/2) | 8.07 | 1.4e-05 | 3.8e-05 |
GO:0019899 | enzyme binding | 100.0% (2/2) | 8.19 | 1.2e-05 | 3.8e-05 |
GO:0065008 | regulation of biological quality | 100.0% (2/2) | 7.97 | 1.6e-05 | 4e-05 |
GO:0097708 | intracellular vesicle | 100.0% (2/2) | 8.23 | 1.1e-05 | 4e-05 |
GO:0031410 | cytoplasmic vesicle | 100.0% (2/2) | 8.23 | 1.1e-05 | 4e-05 |
GO:0007010 | cytoskeleton organization | 100.0% (2/2) | 8.19 | 1.2e-05 | 4e-05 |
GO:0031982 | vesicle | 100.0% (2/2) | 7.97 | 1.6e-05 | 4.1e-05 |
GO:0035556 | intracellular signal transduction | 100.0% (2/2) | 7.54 | 2.9e-05 | 7e-05 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 100.0% (2/2) | 6.5 | 0.000122 | 0.000283 |
GO:0043228 | non-membrane-bounded organelle | 100.0% (2/2) | 6.32 | 0.000156 | 0.000308 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 100.0% (2/2) | 6.37 | 0.000147 | 0.000308 |
GO:0016462 | pyrophosphatase activity | 100.0% (2/2) | 6.4 | 0.000139 | 0.000312 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 100.0% (2/2) | 6.38 | 0.000144 | 0.000312 |
GO:0043232 | intracellular non-membrane-bounded organelle | 100.0% (2/2) | 6.32 | 0.000156 | 0.000317 |
GO:0007165 | signal transduction | 100.0% (2/2) | 6.13 | 0.000204 | 0.000379 |
GO:0006996 | organelle organization | 100.0% (2/2) | 6.15 | 0.0002 | 0.000382 |
GO:0016043 | cellular component organization | 100.0% (2/2) | 5.24 | 0.0007 | 0.001263 |
GO:0071840 | cellular component organization or biogenesis | 100.0% (2/2) | 5.08 | 0.00087 | 0.001529 |
GO:0050794 | regulation of cellular process | 100.0% (2/2) | 4.31 | 0.002541 | 0.004346 |
GO:0050789 | regulation of biological process | 100.0% (2/2) | 4.24 | 0.002804 | 0.004557 |
GO:0035639 | purine ribonucleoside triphosphate binding | 100.0% (2/2) | 4.24 | 0.002799 | 0.004665 |
GO:0016787 | hydrolase activity | 100.0% (2/2) | 4.19 | 0.003007 | 0.004767 |
GO:0065007 | biological regulation | 100.0% (2/2) | 4.14 | 0.003232 | 0.005001 |
GO:0097367 | carbohydrate derivative binding | 100.0% (2/2) | 3.88 | 0.004612 | 0.006662 |
GO:0032553 | ribonucleotide binding | 100.0% (2/2) | 3.89 | 0.004543 | 0.006711 |
GO:0032555 | purine ribonucleotide binding | 100.0% (2/2) | 3.9 | 0.004469 | 0.006756 |
GO:0043227 | membrane-bounded organelle | 100.0% (2/2) | 3.82 | 0.004993 | 0.006762 |
GO:0043231 | intracellular membrane-bounded organelle | 100.0% (2/2) | 3.83 | 0.004919 | 0.006803 |
GO:0036094 | small molecule binding | 100.0% (2/2) | 3.73 | 0.005654 | 0.006806 |
GO:0017076 | purine nucleotide binding | 100.0% (2/2) | 3.85 | 0.004826 | 0.006819 |
GO:1901265 | nucleoside phosphate binding | 100.0% (2/2) | 3.78 | 0.005284 | 0.006869 |
GO:0000166 | nucleotide binding | 100.0% (2/2) | 3.78 | 0.005284 | 0.006869 |
GO:0005515 | protein binding | 100.0% (2/2) | 3.74 | 0.00561 | 0.00688 |
GO:1901363 | heterocyclic compound binding | 100.0% (2/2) | 3.74 | 0.005579 | 0.006974 |
GO:0043168 | anion binding | 100.0% (2/2) | 3.76 | 0.005473 | 0.006975 |
GO:0043226 | organelle | 100.0% (2/2) | 3.62 | 0.006651 | 0.00772 |
GO:0043229 | intracellular organelle | 100.0% (2/2) | 3.62 | 0.00665 | 0.007859 |
GO:0043167 | ion binding | 100.0% (2/2) | 3.28 | 0.010599 | 0.012087 |
GO:0097159 | organic cyclic compound binding | 100.0% (2/2) | 2.8 | 0.020611 | 0.023098 |
GO:0110165 | cellular anatomical entity | 100.0% (2/2) | 2.5 | 0.031232 | 0.034408 |
GO:0003824 | catalytic activity | 100.0% (2/2) | 2.47 | 0.032758 | 0.035488 |
GO:0009987 | cellular process | 100.0% (2/2) | 2.44 | 0.033939 | 0.036165 |
GO:0005575 | cellular_component | 100.0% (2/2) | 2.32 | 0.039968 | 0.041902 |